---
title: "Pre-market hot trades in US stocks: Future Fintech up 8.44% in pre-market"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/248943146.md"
description: "Future Fintech pre-market rose 8.44%; Volcon pre-market rose 164.19%; 22nd Century Group pre-market rose 126.86%; Windtree Therapeutics pre-market rose 37.78%"
datetime: "2025-07-17T09:57:47.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/248943146.md)
  - [en](https://longbridge.com/en/news/248943146.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/248943146.md)
generator: "portal-rs"
---

# Pre-market hot trades in US stocks: Future Fintech up 8.44% in pre-market

**Pre-market Hot Trades in US Stocks**

Future Fintech rose 8.44% in pre-market trading. Based on recent important news:

1.  On June 9, Maifushi's stock price rose nearly 9% in the afternoon due to the accelerated integration of AI applications, showing increased market confidence in the AI sector, which drove Future Fintech's stock price up.

2.  On June 11, the internet finance sector performed well, with high market enthusiasm driving related tech stocks higher.

3.  On June 12, fintech concept stocks surged, with the favorable AI + finance era pushing stock prices up.

**Top Gainers in Pre-market US Stocks**

Volcon rose 164.19% in pre-market trading. Based on recent important news:

1.  On May 27, Volcon announced its first order of 1,000 golf carts from Advanced EV and resumed its stock repurchase plan, leading to a 16.32% increase in stock price in pre-market trading.

2.  On May 28, Volcon launched a new financing plan to support the expansion of its dealer network, causing the stock price to drop by 3.7%.

3.  On June 17, Vanadium Resources signed a memorandum of understanding with a Chinese company, resulting in a 164% increase in stock price.

22nd Century Group rose 126.86% in pre-market trading. Based on recent important news:

1.  On July 15, 22nd Century Group released important documents through the EDGAR system, which may contain key information about the company's future development, leading to a significant increase in stock price.

2.  On July 16, the company issued forward-looking statements regarding cost reductions and regulatory exemptions, enhancing market confidence and further driving up the stock price.

3.  On July 17, an investor relations announcement emphasized the company's expectations regarding business interruption insurance claims, further boosting investor confidence.

Windtree Therapeutics rose 37.78% in pre-market trading. Based on recent important news:

1.  On July 16, Windtree announced a $60 million securities purchase agreement with Build and Build Corp, potentially securing up to $140 million in additional funding, with total subscriptions reaching up to $200 million. This news drove the stock price up by 37.78%.

2.  On July 16, Windtree plans to become the first Nasdaq-listed company to provide direct access to the Binance Smart Chain ecosystem, enhancing market confidence.

3.  On July 17, Windtree entered into a $60 million financing agreement, with funds to be used to launch a BNB asset reserve strategy, further enhancing the company's market position

### Related Stocks

- [FTFT.US](https://longbridge.com/en/quote/FTFT.US.md)

## Related News & Research

- [Myungmoon Pharm Director Lim Gi Sub Raises Stake to 0.32% From 0.31%](https://longbridge.com/en/news/304776084.md)
- [Thermax Limited Just Missed EPS By 30%: Here's What Analysts Think Will Happen Next](https://longbridge.com/en/news/304776846.md)
- [LG Innotek Executive Jang Seung Woo Buys 200 Shares](https://longbridge.com/en/news/304775739.md)
- [Analysts Have Just Cut Their Lloyds Metals and Energy Limited (NSE:LLOYDSME) Revenue Estimates By 12%](https://longbridge.com/en/news/304775901.md)
- [VNT: Three-sector simplification targets $60m+ annual savings; FY26 NPATA growth guidance held](https://longbridge.com/en/news/304774780.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**